The Dissenter cover image

#1005 Joshua May - Neuroethics: Agency in the Age of Brain Science

The Dissenter

00:00

Navigating the Ethics of Pharmaceutical Approvals

This chapter explores the ethical challenges and regulatory hurdles in drug approval by examining the controversial case of Relivrio, a medication for ALS that was recently withdrawn. It emphasizes the conflict between the urgent need for effective treatments and the rigorous standards required in scientific testing, particularly in the realm of costly brain-related therapies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app